DR. RICARDO H BRAU M.D.
Prescription History 1114939949
Neurological Surgery in San Juan, PR

NPI Status: Active since August 12, 2006

Contact Information

400 AVE FD ROOSEVELT
SUITE 511
SAN JUAN, PR
ZIP 00918
Phone: (787) 763-1310
Fax: (787) 766-7607

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. RICARDO H BRAU M.D., an active Neurological Surgery specialist practicing in San Juan, PR. Our medical registry currently tracks 7 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 205 documented patient claims. Among these therapy options, the most frequently utilized medication is Carbamazepine, which accounts for 55 claims alone.

Medication Index


Carbamazepine

Generic Formulation: CarbamazepineSpecialty: Neurosurgery
Provider Metrics Summary
Total Claims 55
30-Day Fills 61.0
Days Supply 1,830
PR State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills24.5
Peer Average Days Supply720
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 175.0% higher than the standard regional baseline profile for PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,732.19 across this reporting matrix range.

Provider Avg Cost Per Claim

$49.68

State Avg Cost Per Claim

$50.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.

Therapeutic Applications

Carbamazepine is used to prevent and control seizures. This medication is known as an anticonvulsant or anti-epileptic drug. It is also used to relieve certain types of nerve pain (such as trigeminal neuralgia). This medication works by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity.

Diclofenac Potassium

Generic Formulation: Diclofenac PotassiumSpecialty: Neurosurgery
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 274
PR State Average Benchmarks
Peer Average Claims64.0
Peer Average 30-Day Fills67.2
Peer Average Days Supply1,467
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 81.3% less volume than the regional standard for practitioners inside PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $469.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$39.11

State Avg Cost Per Claim

$33.07

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.

Therapeutic Applications

See also Warning section. This powder form of diclofenac is used to treat migraine headaches. Diclofenac is not used to prevent migraines from happening or lessen how often you get them. Diclofenac is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling, pain, or fever.

Gabapentin

Generic Formulation: GabapentinSpecialty: Neurosurgery
Provider Metrics Summary
Total Claims 49
30-Day Fills 55.0
Days Supply 1,650
PR State Average Benchmarks
Peer Average Claims262.0
Peer Average 30-Day Fills390.8
Peer Average Days Supply11,611
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 81.3% less volume than the regional standard for practitioners inside PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $476.24 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.72

State Avg Cost Per Claim

$9.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Keppra

Generic Formulation: LevetiracetamSpecialty: Neurosurgery
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 480
PR State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills27.2
Peer Average Days Supply811
Conservative Utilization

This provider writes prescriptions for this formulation 36.0% less frequently than the standard regional baseline metric for practitioners inside PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,460.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$716.27

State Avg Cost Per Claim

$1,156.38

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent.

Therapeutic Applications

Levetiracetam is used to treat seizures (epilepsy). It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have.

Lamotrigine

Generic Formulation: LamotrigineSpecialty: Neurosurgery
Provider Metrics Summary
Total Claims 24
30-Day Fills 40.0
Days Supply 1,200
PR State Average Benchmarks
Peer Average Claims66.0
Peer Average 30-Day Fills73.8
Peer Average Days Supply2,178
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 63.6% less volume than the regional standard for practitioners inside PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $249.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.39

State Avg Cost Per Claim

$8.87

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER.

Therapeutic Applications

Lamotrigine is used alone or with other medications to prevent and control seizures. It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections).

Prednisone

Generic Formulation: PrednisoneSpecialty: Neurosurgery
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 360
PR State Average Benchmarks
Peer Average Claims60.0
Peer Average 30-Day Fills62.0
Peer Average Days Supply1,242
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 80.0% less volume than the regional standard for practitioners inside PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $101.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.42

State Avg Cost Per Claim

$5.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

Therapeutic Applications

Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Tizanidine Hcl

Generic Formulation: Tizanidine HclSpecialty: Neurosurgery
Provider Metrics Summary
Total Claims 37
30-Day Fills 37.0
Days Supply 1,098
PR State Average Benchmarks
Peer Average Claims83.0
Peer Average 30-Day Fills85.6
Peer Average Days Supply2,172
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 55.4% less volume than the regional standard for practitioners inside PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $713.59 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.29

State Avg Cost Per Claim

$10.56

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It works by helping to relax the muscles.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. RICARDO H BRAU M.D. provides transparency into local medical care patterns within San Juan, PR.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Neurological Surgery** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.